LifeSemantics Corp. (347700) - Cash Flow Conversion Efficiency
Based on the latest financial reports, LifeSemantics Corp. (347700) has a cash flow conversion efficiency ratio of -0.313x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-32.00 Billion ≈ $-21.69 Million USD) by net assets (₩102.38 Billion ≈ $69.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 347700 net asset quality score to measure how much of total assets are equity-financed.
LifeSemantics Corp. - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how LifeSemantics Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LifeSemantics Corp. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
LifeSemantics Corp. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LifeSemantics Corp. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Well Lead Med Co Ltd
SHG:603309
|
0.065x |
|
Altia Consultores S.A.
MC:ALC
|
0.169x |
|
Paysign Inc
NASDAQ:PAYS
|
0.341x |
|
Anhui Gourgen Traffic Construction Co Ltd
SHG:603815
|
-0.050x |
|
Guangzhou Hangxin Aviation Technology Co Ltd
SHE:300424
|
0.071x |
|
Core Laboratories NV
NYSE:CLB
|
0.014x |
|
Amper S.A.
MC:AMP
|
-0.602x |
|
Texmaco Rail & Engineering Limited
NSE:TEXRAIL
|
0.088x |
Annual Cash Flow Conversion Efficiency for LifeSemantics Corp. (2017–2025)
The table below shows the annual cash flow conversion efficiency of LifeSemantics Corp. from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see LifeSemantics Corp. (347700) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩63.63 Billion ≈ $43.12 Million |
₩-14.67 Billion ≈ $-9.94 Million |
-0.230x | -24.15% |
| 2024-12-31 | ₩31.25 Billion ≈ $21.18 Million |
₩-5.80 Billion ≈ $-3.93 Million |
-0.186x | +83.78% |
| 2023-12-31 | ₩8.98 Billion ≈ $6.08 Million |
₩-10.27 Billion ≈ $-6.96 Million |
-1.145x | -114.00% |
| 2022-12-31 | ₩9.57 Billion ≈ $6.49 Million |
₩-5.12 Billion ≈ $-3.47 Million |
-0.535x | -37.85% |
| 2021-12-31 | ₩13.06 Billion ≈ $8.85 Million |
₩-5.07 Billion ≈ $-3.43 Million |
-0.388x | +33.09% |
| 2020-12-31 | ₩2.19 Billion ≈ $1.48 Million |
₩-1.27 Billion ≈ $-859.11K |
-0.580x | -160.99% |
| 2019-12-31 | ₩-3.53 Billion ≈ $-2.39 Million |
₩-3.35 Billion ≈ $-2.27 Million |
0.951x | +128.83% |
| 2018-12-31 | ₩607.35 Million ≈ $411.59K |
₩-2.00 Billion ≈ $-1.36 Million |
-3.298x | -252.35% |
| 2017-12-31 | ₩-1.84 Billion ≈ $-1.24 Million |
₩-3.98 Billion ≈ $-2.69 Million |
2.165x | -- |
About LifeSemantics Corp.
Sphere Corp. provides digital healthcare technology, and life care products and services. It develops LifeRecord, a commercial personal health record platform that manages health-related data, including medical records, genome data, and personally generated health data. The company also offers digital healthcare services for consumers, such as non-face-to-face treatment, medication management, an… Read more